2007 - Fellow of the Royal Society of Canada Academy of Science
Transplantation, Kidney, Pathology, Kidney transplantation and Immunology are his primary areas of study. His Transplantation research is multidisciplinary, relying on both Immunosuppression, Azathioprine and Urology. His study on Kidney is covered under Internal medicine.
His Pathology study combines topics in areas such as Transplant glomerulopathy, Antibody and Chronic allograft nephropathy. His Kidney transplantation research incorporates themes from Hazard ratio, Allograft rejection and Acute tubular necrosis, Renal function. His Immunology research includes elements of Regulation of gene expression, Organ transplantation and Intensive care medicine.
Philip F. Halloran mostly deals with Transplantation, Immunology, Kidney, Pathology and Internal medicine. His research in Transplantation intersects with topics in Immunosuppression, Clinical trial, Intensive care medicine and Urology. The concepts of his Urology study are interwoven with issues in Azathioprine, Tacrolimus and Renal function.
Philip F. Halloran is involved in the study of Kidney that focuses on Kidney transplantation in particular. His Pathology study combines topics from a wide range of disciplines, such as Inflammation and Microarray. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology and Cardiology.
His primary areas of investigation include Pathology, Biopsy, Kidney, Immunology and Internal medicine. His biological study deals with issues like Inflammation, which deal with fields such as Parenchyma and T cell. His work deals with themes such as Kidney transplant, Medical diagnosis, Transplantation and Histology, which intersect with Biopsy.
Many of his studies on Transplantation involve topics that are commonly interrelated, such as Immune system. He studies Kidney, focusing on Kidney transplantation in particular. The various areas that Philip F. Halloran examines in his Immunology study include Receptor and Antibody mediated rejection.
The scientist’s investigation covers issues in Pathology, Biopsy, Immunology, Kidney transplantation and Transplantation. His Disease study, which is part of a larger body of work in Pathology, is frequently linked to Diagnostic system, bridging the gap between disciplines. Philip F. Halloran has included themes like Histology, Arteritis, Medical diagnosis and Urology in his Biopsy study.
Philip F. Halloran combines subjects such as Receptor and Gene expression profiling with his study of Immunology. Kidney transplantation is a subfield of Kidney that he tackles. Internal medicine covers he research in Transplantation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Banff 97 working classification of renal allograft pathology
Lorraine C. Racusen;Kim Solez;Robert B. Colvin;Stephen M. Bonsib.
Kidney International (1999)
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
K. Solez;R. B. Colvin;L. C. Racusen;M. Haas.
American Journal of Transplantation (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation.
Henrik Ekberg;Helio Tedesco-Silva;Alper Demirbas;Štefan Vítko.
The New England Journal of Medicine (2007)
Immunosuppressive Drugs for Kidney Transplantation
Philip F. Halloran.
The New England Journal of Medicine (2004)
International standardization of criteria for the histologic diagnosis of renal allograft rejection : the Banff working classification of kidney transplant pathology
K.i.m. Solez;Roy A. Axelsen;Hallgrimur Benediktsson;James F. Burdick.
Kidney International (1993)
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.
J. Sellarés;D. G. de Freitas;M. Mengel;J. Reeve.
American Journal of Transplantation (2012)
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN').
K. Solez;R. B. Colvin;L. C. Racusen;B. Sis.
American Journal of Transplantation (2007)
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.
Lorraine C. Racusen;Robert B. Colvin;Kim Solez;Michael J. Mihatsch.
American Journal of Transplantation (2003)
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
F. Vincenti;R. Kirkman;S. Light;G. Bumgardner.
The New England Journal of Medicine (1998)
A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation
Paul Keown;Pekka Häyry;Peter Morris;Calvin Stiller.
Transplantation (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Alberta
Scott & White Memorial Hospital
University of Minnesota
Johns Hopkins University School of Medicine
Harvard University
University of California, Los Angeles
Mayo Clinic
University of Maryland, Baltimore
University of Pittsburgh
University Hospital of Basel
University of Burgos
University of Alberta
Vrije Universiteit Amsterdam
Applied Materials (United States)
University of California, Santa Cruz
Xi’an Jiaotong-Liverpool University
Natural History Museum
Université Laval
University of Tokyo
University of Waterloo
Langley Research Center
National University of Defense Technology
St. Jude Children's Research Hospital
Australian National University
Queen Mary University of London
University of Lisbon